A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)

NCT04035135 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Guillain-Barré Syndrome

Interventions

DRUG: ANX005
DRUG: Intravenous immunoglobulin

Sponsor

Annexon, Inc.

Collaborators

[object Object]
[object Object]